Company intelligence / Profile preview

AIRS Medical

Seoul, Seoul Special City, South Koreaairsmed.com ↗

Ownership: Private
Employees: ~62
Development stage: Other

Overview

AIRS Medical’s flagship product, SwiftMR™, uses deep learning to accelerate MRI scan times by up to 50% while improving image quality. The solution has been adopted at over 500 institutions worldwide, with more than 140 million scans performed as of early 2025. Clinical studies have demonstrated improved signal-to-noise ratio and resolution compared to standard MRI protocols[1][3][5].

Therapeutic areas: Other
Modalities: DeviceSoftware (AI-based medical imaging enhancement)
Industry: Medical Imaging

Partnerships

ParagonCare (distribution partner in Australia/New Zealand)[4](Also has strategic partnerships expanding presence in the US, Brazil, Germany, Switzerland, UK[5].)

Beyond the preview

Go deeper on AIRS Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIRS Medical.

Explore the full profile